Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

With a market cap of $144.8 billion, New York ... Pfizer raised its full-year revenue guidance to $61 billion - $64 billion and adjusted EPS guidance to $2.75 - $2.95. However, the stock fell ...

Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing ... attractive and discounted stocks. New York-based Pfizer markets a wide range of drugs and ...

Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...

Taking full advantage of the stock market and investing with confidence ... favorable times to buy high-momentum stocks. New York-based Pfizer markets a wide range of drugs and vaccines.